Skip Nav Destination
Issues
15 April 2010
-
Cover Image
Cover Image
![issue cover]()
Automated quantitative analysis (AQUA) of STAT3 in head and neck squamous cell carcinoma (HNSCC) may be a more reliable indicator of STAT3 activation status. The cover features a pseudocolored colocalization image demonstrating compartment assignment. Cytokeratin-Cy3 (green) was used to define the nonnuclear compartment; 4',6-Diamidino-2- phenylindole (DAPI; blue) was used to define the nuclear compartment. For details, see the article by Pectasides and colleagues on page 2427 of this issue.Close Modal - PDF Icon PDF LinkTable of Contents
ISSN 1078-0432
EISSN 1557-3265
Highlights
Molecular Pathways
Human Cancer Biology
Synergistic Antitumor Effect of the Activated PPARγ and Retinoid Receptors on Human Osteosarcoma
Bai-Cheng He; Liang Chen; Guo-Wei Zuo; Wenli Zhang; Yang Bi; Jiayi Huang; Yi Wang; Wei Jiang; Qing Luo; Qiong Shi; Bing-Qiang Zhang; Bo Liu; Xia Lei; Jinyong Luo; Xiaoji Luo; Eric R. Wagner; Stephanie H. Kim; Connie J. He; Yawen Hu; Jikun Shen; Qixin Zhou; Farbod Rastegar; Zhong-Liang Deng; Hue H. Luu; Tong-Chuan He; Rex C. Haydon
Crosstalk between Mast Cells and Pancreatic Cancer Cells Contributes to Pancreatic Tumor Progression
Matthew J. Strouch; Eric C. Cheon; Mohammad R. Salabat; Seth B. Krantz; Elias Gounaris; Laleh G. Melstrom; Surabhi Dangi-Garimella; Edward Wang; Hidayatullah G. Munshi; Khashayarsha Khazaie; David J. Bentrem
The EPHB6 Receptor Tyrosine Kinase Is a Metastasis Suppressor That Is Frequently Silenced by Promoter DNA Hypermethylation in Non–Small Cell Lung Cancer
Jun Yu; Etmar Bulk; Ping Ji; Antje Hascher; Moying Tang; Ralf Metzger; Alessandro Marra; Hubert Serve; Wolfgang E. Berdel; Rainer Wiewroth; Steffen Koschmieder; Carsten Müller-Tidow
Cancer Therapy: Preclinical
CK2 Modulation of NF-κB, TP53, and the Malignant Phenotype in Head and Neck Cancer by Anti-CK2 Oligonucleotides In vitro or In vivo via Sub–50-nm Nanocapsules
Matthew S. Brown; Oumou T. Diallo; Michael Hu; Reza Ehsanian; Xinping Yang; Pattatheyil Arun; Hai Lu; Vicci Korman; Gretchen Unger; Khalil Ahmed; Carter Van Waes; Zhong Chen
Development of a Functional Assay for Homologous Recombination Status in Primary Cultures of Epithelial Ovarian Tumor and Correlation with Sensitivity to Poly(ADP-Ribose) Polymerase Inhibitors
Asima Mukhopadhyay; Ahmed Elattar; Aiste Cerbinskaite; Sarah J. Wilkinson; Yvette Drew; Suzanne Kyle; Gerrit Los; Zdenek Hostomsky; Richard J. Edmondson; Nicola J. Curtin
Establishment and Characterization of a Panel of Human Uveal Melanoma Xenografts Derived from Primary and/or Metastatic Tumors
Fariba Némati; Xavier Sastre-Garau; Cécile Laurent; Jérôme Couturier; Pascale Mariani; Laurence Desjardins; Sophie Piperno-Neumann; Olivier Lantz; Bernard Asselain; Corine Plancher; Delphine Robert; Isabelle Péguillet; Marie-Hélène Donnadieu; Ahmed Dahmani; Marie-Andrée Bessard; David Gentien; Cécile Reyes; Simon Saule; Emmanuel Barillot; Sergio Roman-Roman; Didier Decaudin
Preclinical Evidence that Use of TRAIL in Ewing's Sarcoma and Osteosarcoma Therapy Inhibits Tumor Growth, Prevents Osteolysis, and Increases Animal Survival
Gaëlle Picarda; François Lamoureux; Loïc Geffroy; Pascal Delepine; Tristan Montier; Karine Laud; Franck Tirode; Olivier Delattre; Dominique Heymann; Françoise Rédini
Imaging, Diagnosis, Prognosis
Aprataxin Tumor Levels Predict Response of Colorectal Cancer Patients to Irinotecan-based Treatment
Higinio Dopeso; Silvia Mateo-Lozano; Elena Elez; Stefania Landolfi; Francisco Javier Ramos Pascual; Javier Hernández-Losa; Rocco Mazzolini; Paulo Rodrigues; Sarah Bazzocco; Maria Josep Carreras; Eloy Espín; Manel Armengol; Andrew J. Wilson; John M. Mariadason; Santiago Ramon y Cajal; Josep Tabernero; Simo Schwartz, Jr.; Diego Arango
ERBB2 and TOP2A in Breast Cancer: A Comprehensive Analysis of Gene Amplification, RNA Levels, and Protein Expression and Their Influence on Prognosis and Prediction
Jan C. Brase; Marcus Schmidt; Thomas Fischbach; Holger Sültmann; Hans Bojar; Heinz Koelbl; Birte Hellwig; Jörg Rahnenführer; Jan G. Hengstler; Mathias C. Gehrmann
Serial Monitoring of Circulating Tumor Cells Predicts Outcome of Induction Biochemotherapy plus Maintenance Biotherapy for Metastatic Melanoma
Kazuo Koyanagi; Steven J. O'Day; Peter Boasberg; Michael B. Atkins; He-Jing Wang; Rene Gonzalez; Karl Lewis; John A. Thompson; Clay M. Anderson; Jose Lutzky; Thomas T. Amatruda; Evan Hersh; Jon Richards; Jeffrey S. Weber; Dave S.B. Hoon
A Novel Prognostic Model for Malignant Mesothelioma Incorporating Quantitative FDG-PET Imaging with Clinical Parameters
Anna K. Nowak; Roslyn J. Francis; Michael J. Phillips; Michael J. Millward; Agatha A. van der Schaaf; Jan Boucek; Arthur W. Musk; Melanie J. McCoy; Amanda Segal; Peter Robins; Michael J. Byrne
Nuclear Localization of Signal Transducer and Activator of Transcription 3 in Head and Neck Squamous Cell Carcinoma Is Associated with a Better Prognosis
Eirini Pectasides; Ann-Marie Egloff; Clarence Sasaki; Panteleimon Kountourakis; Barbara Burtness; George Fountzilas; Urania Dafni; Thomas Zaramboukas; Theodoros Rampias; David Rimm; Jennifer Grandis; Amanda Psyrri
Cancer Therapy: Clinical
Expression of p21 Protein Predicts Clinical Outcome in DLBCL Patients Older than 60 Years Treated with R-CHOP but not CHOP: A Prospective ECOG and Southwest Oncology Group Correlative Study on E4494
Jane N. Winter; Shuli Li; Vikas Aurora; Daina Variakojis; Beverly Nelson; Maryla Krajewska; Lijun Zhang; Thomas M. Habermann; Richard I. Fisher; William R. Macon; Mukesh Chhanabhai; Raymond E. Felgar; Eric D. Hsi; L. Jeffrey Medeiros; James K. Weick; Edie A. Weller; Ari Melnick; John C. Reed; Sandra J. Horning; Randy D. Gascoyne
A Phase II Study of PD-0325901, an Oral MEK Inhibitor, in Previously Treated Patients with Advanced Non–Small Cell Lung Cancer
Eric B. Haura; Alejandro D. Ricart; Timothy G. Larson; Philip J. Stella; Lyudmila Bazhenova; Vincent A. Miller; Roger B. Cohen; Peter D. Eisenberg; Paulina Selaru; Keith D. Wilner; Shirish M. Gadgeel
A Phase I Study of Weekly R1507, A Human Monoclonal Antibody Insulin-like Growth Factor-I Receptor Antagonist, in Patients with Advanced Solid Tumors
Razelle Kurzrock; Amita Patnaik; Joseph Aisner; Terri Warren; Stephen Leong; Robert Benjamin; S. Gail Eckhardt; Joseph E. Eid; Gerard Greig; Kai Habben; Cinara D. McCarthy; Lia Gore
Pharmacodynamic Trial of Nimotuzumab in Unresectable Squamous Cell Carcinoma of the Head and Neck: A SENDO Foundation Study
Federico Rojo; Elías Gracias; Nadia Villena; Teresa Cruz; Josep Maria Corominas; Irene Corradino; Mercedes Cedeño; Clara Campas; Marta Osorio; Normando Iznaga; Beatriz Bellosillo; Ana Rovira; Silvia Marsoni; Pere Gascon; Sergio Serrano; Cristiana Sessa; Tania Crombet; Joan Albanell
Advertisement
